11.07.2015 Views

View PDF Edition - U.S. Pharmacist

View PDF Edition - U.S. Pharmacist

View PDF Edition - U.S. Pharmacist

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Nursing Mothers [see Carcinogenesis, Mutagenesis, Impairment of Fertility] Pediatric Use Geriatric Use ]Renal Impairment .Hepatic Impairment .OVERDOSAGE CLINICAL PHARMACOLOGYPharmacodynamics [see Nonclinical Toxicology ] c c NONCLINICAL TOXICOLOGYCarcinogenesis, Mutagenesis, Impairment of Fertility [see Clinical Pharmacology]. PATIENT COUNSELING INFORMATION[see FDA-Approved Patient Labeling in the full prescribing information]Information for Patients Takeda Pharmaceuticals America, Inc. KAPIDEX and Dual Delayed Release are trademarks of Takeda Pharmaceuticals North America, Inc.,and are used under license by Takeda Pharmaceuticals America, Inc.Reference: 1. KAPIDEX (dexlansoprazole) package insert, Takeda Pharmaceuticals America, Inc.©2009 Takeda Pharmaceuticals North America, Inc.LPD-00250 6/09 Printed in U.S.A.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!